Selank Modulates Brain Carboxypeptidase Activity, Potentially Affecting Neuropeptides

Selank is a well-known synthetic anxiolytic (anxiety-reducing) peptide with reported nootropic (cognitive-enhancing) properties. Carboxypeptidases are a class of enzymes that play a crucial role in the post-translational processing of neuropeptide precursors, essentially 'trimming' them into their active forms. Despite Selank's established effects, there has been a gap in understanding how Selank specifically influences the activity of these key neuropeptide-processing enzymes in the nervous tissue.

The researchers observed that a single administration of Selank led to significant and sustained alterations in the activity of both carboxypeptidase H (CPH) and phenylmethylsulfonylfluoride-inhibited carboxypeptidase (PMSF-CP) within the rat nervous tissue. These changes were not transient; they were remarkably long-lasting, with effects still evident and preserved for at least 24 hours post-administration. While specific quantitative changes (e.g., percentage increase or decrease) were not detailed in the abstract, the study clearly indicated a profound and enduring impact on these critical enzyme systems. The most important finding was that a single dose of Selank induced significant and sustained changes in the activity of key neuropeptide-processing enzymes, carboxypeptidase H and PMSF-inhibited carboxypeptidase, with these effects persisting for at least 24 hours in the rat nervous tissue.